Allied Market Research published a research report on the proton therapy market. The findings of the report state that the global market for proton therapy generated $438.33 million in 2021, and is projected to reach $1.6 billion by 2031, witnessing a CAGR of 13.65% from 2022 to 2031. The report offers valuable information on changing market dynamics, major segments, top investment pockets, and competitive scenarios for market players, investors, shareholders, and new entrants.
Download Sample Report:
https://www.linkedin.com/feed/update/urn:li:activity:7005430262218022912
“Increase in prevalence of cancer and increase in the number of healthcare facilities offering proton therapy, along with an increasing number of medical professionals fuel growth of the proton therapy market,” said Onkar Sumant, Manager, Life Sciences at Allied Market Research.
The report provides insights on drivers, restraints, and opportunities to help the market players in devising growth strategies and capitalizing on opportunities. An increase in the prevalence of cancer, a surge in awareness campaigns regarding the benefits of proton therapy, and technological advancements in proton therapy devices drive the growth of the global proton therapy market. On the other hand, the high cost of proton therapy impedes the growth of the market. However, the introduction of proton therapy in emerging economies is expected to offer lucrative opportunities for the key players in the industry.
Get a PDF Sample:
The report also offers a detailed scenario of the impact of the Covid-19 pandemic on the proton therapy market globally. It is helpful for the market players, new entrants, and investors to determine strategies as per the current scenario and improvise the business model for the next few years. The outbreak of the pandemic had a slight negative impact on the growth of the global proton therapy market, especially during the initial period. However, the market recommenced quickly as the demand for proton therapy experienced an incline because of those regular patients who required radiation therapies.
The report offers detailed segmentation of the global proton therapy market based on indication, product type, end-user, and region. These insights are helpful for the new as well as the existing market players to capitalize on the fastest-growing and largest revenue-generating segments to accomplish growth in the future.
Leading market players of the global proton therapy market analyzed in the report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to offer business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.
Contact us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285 |UK: +44-845-528-1300 | Hong Kong: +852-301-84916 | India (Pune): +91-20-66346060|Fax: +1-855-550-5975
Email: help@alliedmarketresearch.com.
Follow us on LinkedIn, Twitter, Facebook, Pinterest, YouTube & Instagram.